… Metastasis in lung cancer is a multifaceted process. In this review, we will dissect the process
in several isolated steps such as angiogenesis, hypoxia, circulation, and establishment of …

… lung cancer patient outcomes leading to curable lung cancer among early-stage diagnoses
and a chronic and manageable disease for patients with advanced and metastatic disease. …

… Although clinical progress in SCLC treatment has been notoriously slow, a better understanding
of the biology of disease has uncovered novel vulnerabilities that might be amenable to …

… Surgical pathology has an important role in the diagnosis and treatment of lung cancer [24].
Despite the remarkable progress in molecular pathology related mainly to the development …

… In conclusion, cancer and fibrosis are both severe lung diseases, and they share biological
pathways. Although the specific genetic and cellular mechanisms are not yet fully understood…

Liquid biopsies have become of interest as minimally invasive ways to monitor treatment
response in lung cancer patients. Circulating tumor DNA (ctDNA) and protein biomarkers are …

… However, significant progress is underway in both the prevention and treatment of lung
cancer. Lung cancer therapy has now emerged as a “role model” for precision …

… effects of lower airway dysbiosis on lung cancer progression, we tested the effects of lower
airway dysbiosis induced by Veillonella parvula in a preclinical lung cancer model (KP mice; …

… In this Review, we provide an overview of the recent progress made in lung cancer biology
and treatment, including the most promising strategies that have already made a notable …

… in patients with advanced non-small cell lung cancer (NSCLC… disease progression. Monthly
Medicare-paid costs were evaluated during the TKI therapy period and following progression…